|
Children and youth with medical complexity
| Children and youth ages 0 to 24 who live with complex chronic conditions and functional limitations, have a high need for health care across settings and services, and a high need for caregiving from informal carers and family. Note: There is no standard definition for the children and youth with medical complexity population. To operationalize this work CADTH has adopted the CIHI definition from 2018 and changed it slightly to use language that is more patient centred. CIHI definition is: “most of these children and youth share 4 characteristics: complex chronic conditions, functional limitations, high health care utilization and a high need for caregiving.” CADTH has changed high health care utilization to high need for health care across settings and services. |
|
Care for children and youth with medical complexity
| Health technologies (any medical devices and diagnostic tests, but not technologies defined as drugs by Health Canada) used in the pathway of care (e.g., screening, diagnosis, treatment, rehabilitation, prognosis) either specifically or primarily, but not necessarily exclusively for children and youth with medical complexity. |
|
Health technology
| Any medical device or diagnostic test; any medical, surgical, or dental procedure; any other non-drug clinical intervention; or model of care. Drugs or technologies defined as drugs by Health Canada (such as most stem cell products) are not in scope for the list. Technologies without direct patient- or caregiver-related outcomes (e.g., building design, care provider training programs) are excluded. |
|
New or emerging health technologies
| Health technologies that are not yet available in Canada or have been available for clinical use for 1 to 2 years with limited use and are in the launch or early post-marketing stage. It may also refer to technologies available in Canada but with diffusion or availability limited to a few health care facilities or centres. An existing technology with new indications could also be considered new or emerging. |
|
Issue relating to the care of children and youth with medical complexity
| Broader considerations (e.g., clinical, health systems planning, social, ethical, legal, or regulatory) that crosscut the provision and delivery of care for children and youth with medical complexity and could impact how such care and related technologies are developed, adopted, or implemented in Canadian health systems. |
